The goal of the proposed training program in Transfusion Biology and Medicine is to prepare M.D., M.D./PhD, or PhD post-doctoral fellows for research careers in the multi-disciplinary field of Transfusion Medicine. This area of medical specialization is not well known, yet its complexity is rapidly evolving. The program described in this application is located Harvard affiliated institutions of the Longwood Medical Campus in Boston, MA. The uniqueness of the program lies in the availability of a broad-based research environment coupled with well-established clinical Transfusion Medicine related activities. The program represents one of few Transfusion Medicine post-doctoral training programs in this country. Research trainees will spend 2-3 years in the laboratory of an experienced mentor. Mentors have been selected among faculty with diverse, but Transfusion Medicine related interests, including cell membrane structure and function, immunobiology of blood cells (platelets, endothelial cells, lymphocytes, dendritic cells), hematopoiesis, genetic engineering of cells used for transfusion. The selected mentors include many senior scientists with documented experience in post- doctoral training, and with current, active federal funding and interlaboratory collaborations. The program plan includes specific steps for minority recruitment, educational programs for trainees in bioethics, grant-writing and laboratory safety. The long-term aim of this program is to attract and train individuals for academic careers in Transfusion Medicine. As has been the case in other medical disciplines, scientists and clinicians often cross-fertilize each other, leading to translational research opportunities and better patient care.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL066987-04
Application #
6752956
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Mondoro, Traci
Project Start
2001-09-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
4
Fiscal Year
2004
Total Cost
$455,204
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Witsch, Thilo; Martinod, Kimberly; Sorvillo, Nicoletta et al. (2018) Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice. J Am Heart Assoc 7:
Kapp, Friedrich G; Perlin, Julie R; Hagedorn, Elliott J et al. (2018) Protection from UV light is an evolutionarily conserved feature of the haematopoietic niche. Nature 558:445-448
Kim, Ah Ram; Sankaran, Vijay G (2018) Thrombopoietin: tickling the HSC's fancy. EMBO Mol Med 10:10-12
Gavillet, Mathilde; Martinod, Kimberly; Renella, Raffaele et al. (2018) A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target. Am J Hematol 93:269-276
Zitomersky, Naamah L; Demers, Melanie; Martinod, Kimberly et al. (2017) ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice. TH Open 1:e11-e23
Blaser, Bradley W; Moore, Jessica L; Hagedorn, Elliott J et al. (2017) CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment. J Exp Med 214:1011-1027
Hudak, Jason E; Alvarez, David; Skelly, Ashwin et al. (2017) Illuminating vital surface molecules of symbionts in health and disease. Nat Microbiol 2:17099
Dotiwala, Farokh; Sen Santara, Sumit; Binker-Cosen, Andres Ariel et al. (2017) Granzyme B Disrupts Central Metabolism and Protein Synthesis in Bacteria to Promote an Immune Cell Death Program. Cell 171:1125-1137.e11
Theodore, Lindsay N; Hagedorn, Elliott J; Cortes, Mauricio et al. (2017) Distinct Roles for Matrix Metalloproteinases 2 and 9 in Embryonic Hematopoietic Stem Cell Emergence, Migration, and Niche Colonization. Stem Cell Reports 8:1226-1241
Martinod, Kimberly; Witsch, Thilo; Erpenbeck, Luise et al. (2017) Peptidylarginine deiminase 4 promotes age-related organ fibrosis. J Exp Med 214:439-458

Showing the most recent 10 out of 87 publications